impact:

rib-x.com

Melinta Therapeutics, founded in 2000 as Rib-X Pharmaceuticals, is an American publicly traded biopharmaceutical firm that focuses on the design and development of novel broad-spectrum antibiotics for the treatment of antibiotic-resistant infections in hospital and community settings. The company is located in New Haven, Connecticut. In mid-2011, Sanofi entered into a global research collaboration and licensing option with the company to develop and commercialize novel antibiotics. It was renamed Melinta Therapeutics in 2013. More information...

According to PR-model, rib-x.com is ranked 1,017,051^st in multilingual Wikipedia, in particular this website is ranked 614,873^rd in English Wikipedia.

The website is placed before ylasavonsote.fi and after xocdiaonline.mobi in the BestRef global ranking of the most important sources of Wikipedia.

#Language

PR-model F-model AR-model

*All Wikipedias

1,017,051^st place

832,839^th place

1,293,659^th place

enEnglish

614,873^rd place

809,474^th place

840,023^rd place

ukUkrainian

82,480^th place

103,037^th place

80,034^th place

ruRussian

310,864^th place

289,674^th place

414,496^th place

zhChinese

191,206^th place

144,969^th place

197,002^nd place

thThai

66,310^th place

56,200^th place

70,210^th place

slSlovenian

45,253^rd place

48,717^th place

45,644^th place